We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IGC market cap is 30.59M. The company's latest EPS is USD -0.1805 and P/E is -2.55.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 331k | 166k | 555k | 291k | 204k |
| Operating Income | -2.24M | -4.04M | -2.14M | -2.49M | -5.62M |
| Net Income | -2.25M | -4.03M | -2.08M | -2.45M | -5.59M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.12M | 4.07M | 898k | 397k | 911k |
| Operating Income | -4.64M | -6.86M | -8.72M | -15.43M | -11.57M |
| Net Income | -4.1M | -7.32M | -8.81M | -15.02M | -11.51M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 20.07M | 17.18M | 15.67M | 16.51M | 11.26M |
| Total Liabilities | 1.75M | 2.27M | 2.47M | 2.41M | 2.21M |
| Total Equity | 18.32M | 14.91M | 13.2M | 14.1M | 9.05M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 34.47M | 28.98M | 35.87M | 26.83M | 17.18M |
| Total Liabilities | 893k | 2.45M | 3.06M | 2.94M | 2.27M |
| Total Equity | 33.57M | 26.54M | 32.8M | 23.89M | 14.91M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -5.53M | -7.05M | -1.47M | -3.09M | -4.67M |
| Investing | 7k | -235k | -5k | 67k | 6k |
| Financing | 101k | 100k | -1,000 | 2.86M | 2.86M |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.33M | -8.68M | -10.8M | -7.46M | -7.05M |
| Investing | -260k | -9.55M | 3.39M | -742k | -235k |
| Financing | 27.6M | -59k | 14.69M | 4.14M | 100k |
| Market Cap | 30.59M |
| Price to Earnings Ratio | -2.55 |
| Price to Sales Ratio | 32.17 |
| Price to Cash Ratio | 9.18 |
| Price to Book Ratio | 1.97 |
| Dividend Yield | - |
| Shares Outstanding | 63.73M |
| Average Volume (1 week) | 498.67k |
| Average Volume (1 Month) | 1.73M |
| 52 Week Change | 34.08% |
| 52 Week High | 0.9099 |
| 52 Week Low | 0.2501 |
| Spread (Intraday) | 0.04 (8.33%) |
| Company Name | IGC Pharma Inc |
| Address |
10224 falls road bethesda, maryland 20854 |
| Website | https://www.igcinc.us |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
